XML 99 R80.htm IDEA: XBRL DOCUMENT v3.25.1
Note 12 - Income Taxes - Components of Net Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Capitalized research expenditures [1] $ 8,148 $ 5,116  
Credits 2,774 2,528  
Allowances and reserves 2,687 3,033  
Stock compensation deductible differences 1,632 1,346  
Operating lease liabilities 1,860 2,182  
Inventories 1,153 668  
Net operating loss 3,219 6,633  
Other 265 187  
Deferred tax assets, gross 21,738 21,693  
Valuation allowance (8,999) (5,975) $ (582)
Deferred tax assets, net 12,739 15,718  
Operating lease right-of-use assets (1,843) (2,120)  
Goodwill and intangible assets (26,854) (28,694)  
Property, plant and equipment (2,273) (2,813)  
Other (579) (579)  
Total deferred tax liabilities (31,549) (34,206)  
Deferred tax asset/(liabilities) $ (18,810) $ (18,488)  
[1] Under the Tax Cut and Jobs Act of 2017, research and development costs are no longer fully deductible and are required to be capitalized and amortized for U.S tax purposes effective January 1, 2022. The mandatory capitalization requirement increases our deferred tax assets and cash tax liabilities.